NO20024679L - Crystalline Pharmaceuticals - Google Patents

Crystalline Pharmaceuticals

Info

Publication number: NO20024679L
Authority: NO; Norway
Prior art keywords: pharmaceuticals; crystalline; crystalline pharmaceuticals
Prior art date: 2000-03-30

Application number

NO20024679A

Other languages

Norwegian (no)

Other versions

NO325005B1 (en

NO20024679D0 (en

Inventor

Daniel A Dickman

Sanjay Chemburkar

James J Fort

Rodger F Henry

David Lechuga-Ballesteros

Yuping Niu

William Porter

Original Assignee

Abbott Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-30

Filing date

2002-09-30

Publication date

2002-09-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27065762&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20024679(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-02-27 Priority claimed from US09/793,536 external-priority patent/US6608198B2/en

2002-09-30 Application filed by Abbott Lab filed Critical Abbott Lab

2002-09-30 Publication of NO20024679D0 publication Critical patent/NO20024679D0/en

2002-09-30 Publication of NO20024679L publication Critical patent/NO20024679L/en

2008-01-14 Publication of NO325005B1 publication Critical patent/NO325005B1/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
- C07D239/10—Oxygen or sulfur atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Virology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
AIDS & HIV (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO20024679A 2000-03-30 2002-09-30 Crystalline forms of lopinavir, pharmaceutical compositions comprising these and their use NO325005B1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US53825700A	2000-03-30	2000-03-30
US09/793,536 US6608198B2 (en)	2000-03-30	2001-02-27	Crystalline pharmaceutical
PCT/US2001/009112 WO2001074787A2 (en)	2000-03-30	2001-03-21	Crystalline pharmaceutical

Publications (3)

Publication Number	Publication Date
NO20024679D0 NO20024679D0 (en)	2002-09-30
NO20024679L true NO20024679L (en)	2002-09-30
NO325005B1 NO325005B1 (en)	2008-01-14

Family

ID=27065762

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20024679A NO325005B1 (en)	2000-03-30	2002-09-30	Crystalline forms of lopinavir, pharmaceutical compositions comprising these and their use

Country Status (22)

Country	Link
EP (1)	EP1268442A2 (en)
JP (1)	JP2003529592A (en)
KR (1)	KR100773258B1 (en)
CN (2)	CN1330639C (en)
AR (2)	AR033360A1 (en)
AU (3)	AU5092001A (en)
BG (1)	BG107165A (en)
BR (1)	BR0109433A (en)
CA (1)	CA2403635A1 (en)
CZ (1)	CZ20023529A3 (en)
HU (1)	HUP0302675A3 (en)
IL (1)	IL151551A0 (en)
MX (1)	MXPA02009559A (en)
MY (1)	MY128296A (en)
NO (1)	NO325005B1 (en)
NZ (1)	NZ521183A (en)
PE (1)	PE20011232A1 (en)
PL (1)	PL359727A1 (en)
SA (2)	SA01220270B1 (en)
SK (1)	SK14832002A3 (en)
TW (1)	TWI284640B (en)
WO (1)	WO2001074787A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6608198B2 (en)	2000-03-30	2003-08-19	Abbott Laboratories	Crystalline pharmaceutical
US8025899B2 (en)	2003-08-28	2011-09-27	Abbott Laboratories	Solid pharmaceutical dosage form
US8445506B2 (en)	2009-02-06	2013-05-21	Hetero Research Foundation	Polymorphs of lopinavir
EP2470189A4 (en) *	2009-08-27	2013-01-23	Merck Sharp & Dohme	METHODS FOR PREPARING HEPATITIS C VIRUS PROTEASE INHIBITORS
CN112830899A (en) *	2021-01-18	2021-05-25	合肥华方医药科技有限公司	Novel lopinavir crystal form and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5914332A (en) *	1995-12-13	1999-06-22	Abbott Laboratories	Retroviral protease inhibiting compounds
WO1998057648A1 (en) *	1997-06-16	1998-12-23	Vertex Pharmaceuticals Incorporated	Methods of increasing the bioavailability of stable crystal polymorphs of a compound

2001
- 2001-03-07 MY MYPI20011034A patent/MY128296A/en unknown
- 2001-03-21 PL PL35972701A patent/PL359727A1/en not_active Application Discontinuation
- 2001-03-21 SK SK1483-2002A patent/SK14832002A3/en not_active Application Discontinuation
- 2001-03-21 MX MXPA02009559A patent/MXPA02009559A/en active IP Right Grant
- 2001-03-21 IL IL15155101A patent/IL151551A0/en unknown
- 2001-03-21 NZ NZ521183A patent/NZ521183A/en not_active IP Right Cessation
- 2001-03-21 CZ CZ20023529A patent/CZ20023529A3/en unknown
- 2001-03-21 BR BR0109433-5A patent/BR0109433A/en not_active Application Discontinuation
- 2001-03-21 EP EP01924250A patent/EP1268442A2/en not_active Withdrawn
- 2001-03-21 KR KR1020027012849A patent/KR100773258B1/en not_active Ceased
- 2001-03-21 AU AU5092001A patent/AU5092001A/en active Pending
- 2001-03-21 CA CA002403635A patent/CA2403635A1/en not_active Abandoned
- 2001-03-21 AU AU2001250920A patent/AU2001250920B2/en not_active Revoked
- 2001-03-21 JP JP2001572482A patent/JP2003529592A/en active Pending
- 2001-03-21 CN CNB018076882A patent/CN1330639C/en not_active Expired - Lifetime
- 2001-03-21 WO PCT/US2001/009112 patent/WO2001074787A2/en not_active Ceased
- 2001-03-21 HU HU0302675A patent/HUP0302675A3/en unknown
- 2001-03-21 CN CNA2007101123988A patent/CN101066952A/en active Pending
- 2001-03-29 AR ARP010101522A patent/AR033360A1/en not_active Application Discontinuation
- 2001-03-30 PE PE2001000299A patent/PE20011232A1/en not_active Application Discontinuation
- 2001-05-02 TW TW090107717A patent/TWI284640B/en active
- 2001-08-07 SA SA01220270A patent/SA01220270B1/en unknown
- 2001-08-07 SA SA06270303A patent/SA06270303B1/en unknown
2002
- 2002-09-30 NO NO20024679A patent/NO325005B1/en not_active Application Discontinuation
- 2002-10-03 BG BG107165A patent/BG107165A/en unknown
2005
- 2005-06-29 AR ARP050102702A patent/AR049560A2/en unknown
2006
- 2006-09-27 AU AU2006222711A patent/AU2006222711A1/en not_active Abandoned

Also Published As

Publication number	Publication date
NO325005B1 (en)	2008-01-14
AR033360A1 (en)	2003-12-17
CN1330639C (en)	2007-08-08
TWI284640B (en)	2007-08-01
AU5092001A (en)	2001-10-15
AR049560A2 (en)	2006-08-16
AU2001250920B2 (en)	2006-06-29
CN1422259A (en)	2003-06-04
MXPA02009559A (en)	2003-05-21
KR20030011807A (en)	2003-02-11
BG107165A (en)	2003-07-31
WO2001074787A3 (en)	2002-02-07
WO2001074787A2 (en)	2001-10-11
SA06270303B1 (en)	2009-08-02
HUP0302675A3 (en)	2004-03-29
PL359727A1 (en)	2004-09-06
JP2003529592A (en)	2003-10-07
HUP0302675A2 (en)	2003-12-29
MY128296A (en)	2007-01-31
PE20011232A1 (en)	2001-12-08
NO20024679D0 (en)	2002-09-30
IL151551A0 (en)	2003-04-10
CZ20023529A3 (en)	2003-02-12
CA2403635A1 (en)	2001-10-11
EP1268442A2 (en)	2003-01-02
BR0109433A (en)	2004-08-10
CN101066952A (en)	2007-11-07
SK14832002A3 (en)	2003-02-04
SA01220270B1 (en)	2006-11-14
NZ521183A (en)	2004-03-26
KR100773258B1 (en)	2007-11-05
AU2006222711A1 (en)	2006-10-19

Publication	Publication Date	Title
NO20003968D0 (en)	2000-08-04	Pharmaceuticals
NO20026196L (en)	2003-02-24	Kinazolinditosylatsalt compounds
DK1226127T3 (en)	2009-10-19	Substituted phenylsulfamoylcarboxamides
DK1619192T3 (en)	2010-03-29	Aryl-condensed azapolycyclic compounds
DE60114153D1 (en)	2006-03-02	SUBSTITUTED ARYLPYRAZINE
AR028393A1 (en)	2003-05-07	SUBSTITUTED IMINOAZIDS
NO20020030D0 (en)	2002-01-04	Crystalline 1-methylcarbapenem compounds
DK1331972T3 (en)	2007-11-05	Pharmaceuticals
ID29755A (en)	2001-10-11	COMPOUND ORGANOSYLICONE
DE50112662D1 (en)	2007-08-09	SUBSTITUTED BENZOYLCYCLOHEXENONE
AR028302A1 (en)	2003-05-07	SUBSTITUTED FENILURACILOS
IT250181Y1 (en)	2003-07-24	IMPROVED CASE FOR RIVOLELLA
DE60130137D1 (en)	2007-10-04	CRYSTALLIZATION PROCESS
ATE372338T1 (en)	2007-09-15	DESHALOGEN COMPOUNDS
NO20030303L (en)	2003-03-20	Calcilitic compounds
NO20031837D0 (en)	2003-04-24	Calcilitic compounds
NO20023508L (en)	2002-07-23	Calcilitic compounds
NO20024679L (en)	2002-09-30	Crystalline Pharmaceuticals
FI20001655L (en)	2002-01-13	Crystallization method
EE200300045A (en)	2004-12-15	Crystalline drug substance
SE0001187D0 (en)	2000-04-03	Crystalline form
SE0001422D0 (en)	2000-04-17	Crystalline form
DE50104937D1 (en)	2005-02-03	configuration unit
SE9904417D0 (en)	1999-12-03	Crystalline form
SE9902940D0 (en)	1999-08-18	Pharmaceuticals

Legal Events

Date	Code	Title	Description
2020-04-06	FC2A	Withdrawal, rejection or dismissal of laid open patent application